Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q1

Medical Cannabis and Cannabinoids

SwitzerlandComplementary and Alternative Medicine (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)ISSN-matched source record
Q1Ranking
—Impact Factor (year unverified)
19H-index (SCImago 2025)
0.705SJR (2025)
2018-2026Coverage

About Medical Cannabis and Cannabinoids

Medical Cannabis and Cannabinoids is a scholarly journal published by S. Karger AG. SCImago 2025 lists it in Q1, with an SJR of 0.705 and H-index of 19.

Coverage: 2018-2026. Research categories: Complementary and Alternative Medicine (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-11-09. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 980 CHF; 1080 USD; 930 EUR
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationPMC, Portico
Reported submission-to-publication time16 weeks on average; not a guarantee
Openly licensed content since2018 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2504-3889
ISSN-L2504-3889
Source typeJournal
Publisher / hosting organisationKarger Publishers
Publisher country codeCH
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex161
Citations recorded in OpenAlex2,236
OpenAlex H-index25
Years represented in OpenAlex1999–2025 (not the founding or closing dates)

Topics in published research

Cannabis and Cannabinoid Research; Psychedelics and Drug Studies; Substance Abuse Treatment and Outcomes; Forensic Toxicology and Drug Analysis; Prenatal Substance Exposure Effects; Opioid Use Disorder Treatment.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit